Crizotinib is an orally administered small molecule inhibitor targeting the c-Met/HGFR tyrosine kinase, exhibiting potential antineoplastic properties. It is widely used in cancer research, particularly in studies involving ALK and ROS1-driven tumors, with applications in both in vitro cellular assays and in vivo xenograft models.
Molekulargewicht:
510.39
CAS Nummer:
[877399-53-6]
Formel:
C23H26Cl2FN5O3
Target-Kategorie:
ALK,Others,c-Met/HGFR,ROS Kinase
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten